-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ChWrenGydeF2oGs8DaYBFBrK0mKbZ7FcoBpFvLCKUO5x6apx8GpTTw3p/iaN/21p 32OAjTVbH1yJndSOZEiFbw== 0001157523-07-004427.txt : 20070502 0001157523-07-004427.hdr.sgml : 20070502 20070502160544 ACCESSION NUMBER: 0001157523-07-004427 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070502 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070502 DATE AS OF CHANGE: 20070502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 07810735 BUSINESS ADDRESS: STREET 1: 100 POTRERO AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 100 POTRERO AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94103 8-K 1 a5392052.txt DOLBY LABORATORIES, INC. 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2007 ------------------------ DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-32431 90-0199783 -------- --------- ---------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 100 Potrero Avenue San Francisco, CA 94103-4813 (Address of principal executive offices) (Zip Code) (415) 558-0200 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ Section 2 - Financial Information ITEM 2.02 Results of Operations and Financial Condition. The following information is intended to be furnished under Item 2.02 of Form 8-K, "Results of Operations and Financial Condition." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On May 2, 2007, Dolby Laboratories, Inc. issued a press release announcing its financial results for its fiscal quarter ended March 30, 2007. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Section 9 - Financial Statements and Exhibits ITEM 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith: Exhibit No. Description - ----------- ----------- 99.1 Press Release of Dolby Laboratories, Inc. dated May 2, 2007 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOLBY LABORATORIES, INC. By: /s/ Kevin J. Yeaman ----------------------- Kevin J. Yeaman Chief Financial Officer Date: May 2, 2007 3 EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Press Release of Dolby Laboratories, Inc. dated May 2, 2007 4 EX-99.1 2 a5392052ex991.txt EXHIBIT 99.1 Exhibit 99.1 Dolby Laboratories Reports FY 2007 Second Quarter Results Second Quarter Net Income Tops $39 Million on Revenue of $129 Million SAN FRANCISCO--(BUSINESS WIRE)--May 2, 2007--Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the second quarter of fiscal year 2007. For the second quarter, Dolby reported total revenue of $129.0 million, compared to $104.7 million for the second quarter of fiscal 2006, an increase of 23 percent. Second quarter net income was $39.1 million, or $0.34 per diluted share, compared to $28.0 million, or $0.25 per diluted share, for the second quarter of fiscal 2006. Net income for the second quarter of fiscal 2007 reflected stock-based compensation expense of $4.8 million compared to $5.1 million in the second quarter of fiscal 2006. In the first quarter of fiscal 2007 earnings call, Dolby disclosed that it expected to resolve certain contractual matters with an existing licensee. In the second quarter of fiscal 2007, the Company resolved these contractual matters and recognized revenue of $7.7 million related to prior quarters. "We have made great progress extending Dolby technologies into newer markets, such as digital television. We continue to work closely with content producers and consumer electronics manufacturers to promote the creation and playback of an immersive digital experience through Dolby technologies, whether in DVD, broadcast, personal computer, gaming, digital cinema, or portable devices," said Bill Jasper, President and Chief Executive Officer, Dolby Laboratories. Guidance For fiscal 2007, Dolby now expects revenue to be $435 million to $450 million. Net income is now expected to be $110 million to $115 million. Consequently, earnings per diluted share are now expected to be approximately $0.95 to $1.00. While stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby continues to expect stock-based compensation expense for the full year to be between $20 million and $22 million. The Company's Conference Call Information Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby's second quarter fiscal 2007 financial results at 2:00 p.m. PT/5:00 p.m. ET, Wednesday, May 2, 2007. Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 866-293-8970. International callers can access the conference call at 913-312-1230. A replay of the call will be available beginning at 5:00 p.m. PT on May 2, 2007 until 9 p.m. PT on May 9, 2007 at 888-203-1112 (international callers can access the replay by dialing 719-457-0820) using confirmation code 7297634. An archived version of the teleconference will also be available on www.dolby.com. Forward Looking Statements Certain statements in this press release, including statements relating to Dolby's expectations regarding revenue, net income, earnings per diluted share, and stock-based compensation expense for the fiscal year ending September 28, 2007 and Dolby's expectations concerning extending its technologies into newer markets and continuing to work with content producers and consumer electronics manufacturers to promote the creation and playback of an immersive digital experience through Dolby technologies, and the benefits, including long-term growth opportunities, that may be derived therefrom are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including the DVD, broadcast, personal computer, gaming or portable device markets, and trends relating to the development of additional and newer markets for Dolby technologies; pricing pressures; the timing of Dolby's receipt of royalty reports and/or payments from its licensees; Dolby's accuracy of calculation of royalties due to its licensors; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; the development and growth of the market for digital cinema and Dolby's ability to successfully penetrate this market; Dolby's ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, by acquiring businesses or technologies; and other risks detailed in Dolby's Securities and Exchange Commission filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent Quarterly Report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. About Dolby Laboratories Dolby Laboratories develops and delivers products and technologies that make the entertainment experience more realistic and immersive. For more than four decades, Dolby has been at the forefront of defining high-quality audio and surround sound in cinema, broadcast, home audio systems, cars, DVDs, headphones, games, televisions, and personal computers. For more information about Dolby Laboratories or Dolby(R) technologies, please visit www.dolby.com. Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S07/18268 DLB-F DOLBY LABORATORIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Fiscal Quarter Fiscal Year-to-Date Ended Ended ------------------- ------------------- March 31, March 30, March 31, March 30, 2006 2007 2006 2007 --------- --------- --------- --------- (unaudited) (in thousands, except per share amounts) Revenue: Licensing $ 83,183 $106,642 $152,165 $189,017 Product sales 15,708 15,469 31,712 30,679 Services 5,833 6,899 11,872 13,756 --------- --------- --------- --------- Total revenue 104,724 129,010 195,749 233,452 --------- --------- --------- --------- Cost of revenue: Cost of licensing 7,177 10,149 13,778 17,809 Cost of product sales (1) 6,883 7,714 19,564 16,400 Cost of services (1) 2,338 2,824 5,227 5,507 --------- --------- --------- --------- Total cost of revenue 16,398 20,687 38,569 39,716 --------- --------- --------- --------- Gross margin 88,326 108,323 157,180 193,736 --------- --------- --------- --------- Operating expenses: Selling, general and administrative (1) 38,584 42,525 75,121 79,836 Research and development (1) 8,363 10,960 16,305 19,796 Gain on settlements - (1,500) - (1,500) --------- --------- --------- --------- Total operating expenses 46,947 51,985 91,426 98,132 --------- --------- --------- --------- Operating income 41,379 56,338 65,754 95,604 Other income, net 4,594 5,932 8,293 11,359 --------- --------- --------- --------- Income before provision for income taxes and controlling interest 45,973 62,270 74,047 106,963 Provision for income taxes 17,652 22,776 28,138 37,228 --------- --------- --------- --------- Income before controlling interest 28,321 39,494 45,909 69,735 Controlling interest in net income (342) (399) (661) (747) --------- --------- --------- --------- Net income $ 27,979 $ 39,095 $ 45,248 $ 68,988 ========= ========= ========= ========= Basic earnings per share $ 0.27 $ 0.36 $ 0.43 $ 0.64 Diluted earnings per share $ 0.25 $ 0.34 $ 0.41 $ 0.61 Weighted-average shares outstanding (basic) 105,254 109,055 104,774 108,501 Weighted-average shares outstanding (diluted) 111,387 113,412 111,056 113,165 (1) Stock-based compensation included above was classified as follows: Cost of product sales $ 196 $ 192 $ 398 $ 410 Cost of services 126 31 256 68 Selling, general and administrative 4,106 3,762 8,210 7,621 Research and development 663 772 1,336 1,519 DOLBY LABORATORIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS September 29, 2006 March 30, 2007 ------------------ -------------- (unaudited) (in thousands) ASSETS Current assets: Cash and cash equivalents $363,537 $337,401 Short-term investments 122,162 194,992 Accounts receivable, net 23,550 30,889 Inventories 11,104 13,212 Income tax receivable 1,371 14,770 Deferred income taxes 44,568 45,860 Prepaid expenses and other current assets 6,340 13,067 ------------------ -------------- Total current assets 572,632 650,191 Property, plant and equipment, net 76,995 79,696 Intangible assets, net 14,954 14,625 Goodwill 23,188 24,524 Long-term investments 32,909 72,275 Long-term deferred income taxes 11,100 9,323 Other assets 7,510 8,668 ------------------ -------------- Total assets $739,288 $859,302 ================== ============== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities $ 79,336 $ 89,613 Income taxes payable 5,719 6,491 Current portion of debt 1,441 1,506 Deferred revenue 6,358 10,350 ------------------ -------------- Total current liabilities 92,854 107,960 Long-term debt 10,893 10,351 Long-term deferred revenue 4,562 5,305 Other non-current liabilities 16,780 17,289 ------------------ -------------- Total liabilities 125,089 140,905 Controlling interest 19,911 21,201 Stockholders' equity: Class A common stock 37 40 Class B common stock 70 69 Additional paid-in capital 323,449 352,740 Retained earnings 266,918 335,906 Accumulated other comprehensive income 3,814 8,441 ------------------ -------------- Total stockholders' equity 594,288 697,196 ------------------ -------------- Total liabilities and stockholders' equity $739,288 $859,302 ================== ============== CONTACT: Dolby Laboratories Alex Hughes, 415-645-4572 (Investors) investor@dolby.com Paula Dunn, 415-645-5000 (Media) news@dolby.com -----END PRIVACY-ENHANCED MESSAGE-----